Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-000986
Filing Date
2018-01-12
Accepted
2018-01-12 16:10:38
Documents
1
Period of Report
2018-01-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12215
  Complete submission text file 0000899243-18-000986.txt   13694
Mailing Address C/O POINT THERAPEUTICS INC 125 SUMMER STREET SUITE 1840 BOSTON MA 02110
Business Address
DUFFY MICHAEL P (Reporting) CIK: 0001237200 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36569 | Film No.: 18526091

Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances